Top Markets
Coin of the day
PLx Pharma Inc. PLx Pharma Inc.

PLx Pharma Inc.

PLXP
Classement en actions #41011
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
Prix de l'action
$0.00575
Dernière synchronisation: 2023-05-23
Capitalisation boursière
$51.30K
Changement (1 jour)
-17.86%
Changement (1 an)
0.00%
Pays
US
Échange PLx Pharma Inc. (PLXP)

Catégorie

Historique du rendement du dividende pour PLx Pharma Inc. (PLXP)
Le rendement du dividende (TTM) de PLx Pharma Inc. (symbole boursier : PLXP) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de PLx Pharma Inc. (PLXP) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes